Results 91 to 100 of about 368,779 (305)

Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features.

Gastroenterology, 2019
BACKGROUND & AIMS Intraductal papillary mucinous neoplasms (IPMNs) are regarded as precursors of pancreatic ductal adenocarcinomas (PDAs), but little is known about the mechanism of progression. This makes it challenging to assess cancer risk in patients
Y. Omori, Y. Ono, M. Tanino, H. Karasaki, H. Yamaguchi, T. Furukawa, Katsuro Enomoto, J. Ueda, Atsuko Sumi, Jin Katayama, Miho Muraki, Kenzui Taniue, Kuniyuki Takahashi, Y. Ambo, T. Shinohara, H. Nishihara, J. Sasajima, H. Maguchi, Y. Mizukami, T. Okumura, S. Tanaka   +20 more
semanticscholar   +1 more source

Mucinous Bladder Adenocarcinoma: Case Report and Literature Review

Case Reports in Urology, 2015
Primary mucinous adenocarcinoma is an extremely rare type of bladder cancer, with aggressive behavior and poor response to chemotherapy and radiotherapy. The symptoms are similar to those of other bladder tumors. Surgery is the main treatment and remains
Bruno Mello R. Santos, Julia Duarte de Souza, Rachel Silviano Brandão Correa Lima, Enaldo Melo de Lima   +3 more
doaj   +1 more source

Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatments. [PDF]

, 2018
In this study we utilized data on patient responses to guided treatments, and we evaluated their benefit for a non-small cell lung cancer cohort. The recommended therapies used were predicted using tumor molecular profiles that involved a range of ...
Alifrangis, C, Belluz, LDB, Carter, P, Cereser, B, Chandrasinghe, P, Krell, J, Lim, E, Moderau, N, Poyia, F, Stebbing, J, Tabassum, N, Zhang, H   +11 more
core   +2 more sources

Determining the date of diagnosis – is it a simple matter? The impact of different approaches to dating diagnosis on estimates of delayed care for ovarian cancer in UK primary care [PDF]

, 2009
Background Studies of cancer incidence and early management will increasingly draw on routine electronic patient records. However, data may be incomplete or inaccurate.
A Majeed, A Rosemary Tate, A Verdecchia, AB Ryerson, Alexander GR Martin, B Rachet, B Yawn, BA Goff, BA Goff, BA Goff, CR Bankhead, F Berrino, Jackie A Cassell, JMJ Kirwan, K Sikora, M Richards, ML Wynn, MP Coleman, R Horton, R Jones, R Lawrenson, Sarah R Anderson, SW Pascoe, Tarita Murray-Thomas, VL Allgar, VL Allgar, W Hamilton, W Hamilton   +27 more
core   +3 more sources

Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression

OncoTarget, 2017
NRG1 fusions were recently reported as a new molecular feature of Invasive Mucinous Adenocarcinoma (IMA) of the lung. The NRG1 chimeric ligand acts as a strong inductor of phosphorylation and tyrosine kinase activity of the ErbB2/ErbB3 heterodimer, thus ...
D. Trombetta, P. Graziano, A. Scarpa, A. Sparaneo, G. Rossi, A. Rossi, M. Di Maio, D. Antonello, A. Mafficini, F. Fabrizio, M. Manzorra, Teresa Balsamo, Flavia Centra, M. Simbolo, A. Pantalone, M. Notarangelo, P. Parente, Maria Cecilia Lucia Dimitri, A. Bonfitto, F. Fiordelisi, C. Storlazzi, A. L'Abbate, M. Taurchini, E. Maiello, V. Fazio, L. Muscarella   +25 more
semanticscholar   +1 more source

Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lung

OncoTarget, 2016
The neuregulin 1 (NRG1) fusion is a recently identified novel driver oncogene in invasive mucinous adenocarcinoma of the lung (IMA). After identification of a case of SLC3A2-NRG1 in a patient with IMA, we verified this fusion gene in a cohort of 59 ...
Dong-Hoon Shin, Donghoon Lee, Dong Wan Hong, Seung Hyun Hong, Jung-Ah Hwang, Byung Il Lee, H. You, Geon Kook Lee, In-Hoo Kim, Yeon-Su Lee, Ji-Youn Han   +10 more
semanticscholar   +1 more source

Primary mucinous adenocarcinoma of the renal pelvis

Urological Science, 2014
Mucinous adenocarcinoma of the renal pelvis is a rare disease and preoperative diagnosis is difficult. It often presents with a mucinous-like discharge and is associated with prolonged irritation of inflammation or infection.
Hsiang-Ying Lee, Mei-Yu Jang, Wen-Jeng Wu, Jung-Tsung Shen, Hsun-Shuan Wang, Shu-Fang Chang, Ki-Jiun Tsai   +6 more
doaj   +1 more source

In Vitro Chemosensitivity Using the Histoculture Drug Response Assay in Human Epithelial Ovarian Cancer [PDF]

, 2012
The choice of chemotherapeutic drugs to treat patients with epithelial ovarian cancer has not depended on individual patient characteristics. We have investigated the correlation between in vitro chemosensitivity, as determined by the histoculture drug ...
Kim, Dae-Yeon, Kim, Jong-Hyeok, Kim, Moon-Bo, Kim, Yong-Man, Kim, Young-Tak, Lee, Shin-Wha, Nam, Joo-Hyun   +6 more
core   +1 more source

NKX3.1 Expression in Salivary Gland “Intraductal” Papillary Mucinous Neoplasm: A Low-Grade Subtype of Salivary Gland Mucinous Adenocarcinoma

Head and Neck Pathology, 2022
Masato Nakaguro, P. Sadow, R. Hu, Hikaru Hattori, K. Kuwabara, T. Tsuzuki, M. Urano, T. Nagao, W. Faquin   +8 more
semanticscholar   +1 more source

Diagnosis, clinicopathological characteristics and prognosis of pulmonary mucinous adenocarcinoma

Oncology Letters, 2017
Primary pulmonary mucinous adenocarcinoma (PPMA) is an uncommon subtype of lung adenocarcinoma. The present study attempted to clarify the diagnosis, clinicopathological characteristics, and pathologic significance of epithelial growth factor receptor ...
F. Sun, Pengcheng Wang, Yiming Zheng, Weiguang Jia, Fuxing Liu, W. Xiao, Jingjing Bao, Song Wang, Kaijin Lu   +8 more
semanticscholar   +1 more source